DexCom Debt to Equity Ratio 2006-2019 | DXCM
Current and historical debt to equity ratio values for DexCom (DXCM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. DexCom debt/equity for the three months ending June 30, 2019 was 1.56.
| DexCom Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-06-30 | $1.07B | $0.69B | 1.56 |
| 2019-03-31 | $1.05B | $0.67B | 1.57 |
| 2018-12-31 | $1.01B | $0.66B | 1.52 |
| 2018-09-30 | $0.34B | $0.56B | 0.60 |
| 2018-06-30 | $0.34B | $0.48B | 0.70 |
| 2018-03-31 | $0.33B | $0.42B | 0.79 |
| 2017-12-31 | $0.33B | $0.42B | 0.78 |
| 2017-09-30 | $0.32B | $0.38B | 0.84 |
| 2017-06-30 | $0.32B | $0.35B | 0.91 |
| 2017-03-31 | $0.00B | $0.28B | 0.00 |
| 2016-12-31 | $0.00B | $0.28B | 0.00 |
| 2016-09-30 | $0.00B | $0.26B | 0.00 |
| 2016-06-30 | $0.00B | $0.25B | 0.00 |
| 2016-03-31 | $0.00B | $0.23B | 0.00 |
| 2015-12-31 | $0.00B | $0.22B | 0.00 |
| 2015-09-30 | $0.00B | $0.19B | 0.00 |
| 2015-06-30 | $0.00B | $0.17B | 0.01 |
| 2015-03-31 | $0.00B | $0.15B | 0.01 |
| 2014-12-31 | $0.00B | $0.14B | 0.02 |
| 2014-09-30 | $0.00B | $0.12B | 0.03 |
| 2014-06-30 | $0.00B | $0.10B | 0.04 |
| 2014-03-31 | $0.00B | $0.09B | 0.05 |
| 2013-12-31 | $0.01B | $0.08B | 0.06 |
| 2013-09-30 | $0.01B | $0.08B | 0.07 |
| 2013-06-30 | $0.01B | $0.07B | 0.08 |
| 2013-03-31 | $0.01B | $0.07B | 0.09 |
| 2012-12-31 | $0.01B | $0.08B | 0.09 |
| 2012-09-30 | $0.00B | $0.08B | 0.00 |
| 2012-06-30 | $0.00B | $0.09B | 0.00 |
| 2012-03-31 | $0.00B | $0.10B | 0.00 |
| 2011-12-31 | $0.00B | $0.11B | 0.00 |
| 2011-09-30 | $0.00B | $0.11B | 0.00 |
| 2011-06-30 | $0.00B | $0.12B | 0.00 |
| 2011-03-31 | $0.00B | $0.05B | 0.00 |
| 2010-12-31 | $0.00B | $0.06B | 0.00 |
| 2010-09-30 | $0.00B | $0.04B | 0.03 |
| 2010-06-30 | $0.00B | $0.04B | 0.08 |
| 2010-03-31 | $0.01B | $0.05B | 0.11 |
| 2009-12-31 | $0.05B | $-0.02B | -2.48 |
| 2009-09-30 | $0.05B | $-0.01B | -4.91 |
| 2009-06-30 | $0.00B | $0.00B | 0.99 |
| 2009-03-31 | $0.04B | $0.02B | 2.82 |
| 2008-12-31 | $0.04B | $-0.02B | -2.15 |
| 2008-09-30 | $0.06B | $-0.03B | -2.26 |
| 2008-06-30 | $0.00B | $-0.02B | -0.02 |
| 2008-03-31 | $0.06B | $-0.00B | -21.71 |
| 2007-12-31 | $0.06B | $0.01B | 8.58 |
| 2007-09-30 | $0.06B | $0.02B | 3.54 |
| 2007-06-30 | $0.06B | $0.03B | 2.31 |
| 2007-03-31 | $0.06B | $0.04B | 1.71 |
| 2006-12-31 | $0.00B | $0.06B | 0.04 |
| 2006-09-30 | $0.00B | $0.07B | 0.03 |
| 2006-06-30 | $0.00B | $0.08B | 0.02 |
| 2006-03-31 | $0.00B | $0.04B | 0.00 |
| 2005-12-31 | $0.00B | $0.05B | 0.00 |
| 2005-09-30 | $0.00B | $0.06B | 0.00 |
| 2005-06-30 | $0.00B | $0.07B | 0.00 |
| 2005-03-31 | $0.00B | $-0.06B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $14.456B | $1.032B |
| Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $109.454B | 23.32 |
| Intuitive Surgical (ISRG) | United States | $57.612B | 50.39 |
| Edwards Lifesciences (EW) | United States | $44.757B | 43.56 |
| IDEXX Laboratories (IDXX) | United States | $23.509B | 58.98 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $19.957B | 13.22 |
| Teleflex (TFX) | United States | $17.035B | 36.16 |
| Olympus (OCPNY) | Japan | $16.189B | 121.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.665B | 0.00 |
| Hologic (HOLX) | United States | $13.317B | 21.02 |
| STERIS (STE) | Ireland | $12.870B | 29.68 |
| Sysmex ADR (SSMXY) | Japan | $12.420B | 33.48 |
| Varian Medical Systems (VAR) | United States | $9.773B | 23.38 |
| ABIOMED (ABMD) | United States | $8.715B | 49.89 |
| Masimo (MASI) | United States | $7.964B | 48.32 |
| SARTORIUS AG (SARTF) | Germany | $6.158B | 54.71 |
| Integra LifeSciences Holdings (IART) | United States | $5.135B | 22.91 |
| Penumbra (PEN) | United States | $5.054B | 181.56 |
| Elekta AB (EKTAY) | Sweden | $4.932B | 39.35 |
| Globus Medical (GMED) | United States | $4.827B | 30.64 |
| LivaNova (LIVN) | United Kingdom | $3.751B | 28.60 |
| Cantel Medical (CMD) | United States | $3.706B | 37.59 |
| Tandem Diabetes Care (TNDM) | United States | $3.350B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.662B | 233.44 |
| Nihon Kohden (NHNKY) | Japan | $2.529B | 25.45 |
| Nevro (NVRO) | United States | $2.495B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.473B | 17.49 |
| Glaukos (GKOS) | United States | $2.210B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.724B | 31.97 |
| Silk Road Medical (SILK) | United States | $1.230B | 0.00 |
| Veracyte (VCYT) | United States | $1.205B | 0.00 |
| OPKO Health (OPK) | United States | $1.170B | 0.00 |
| Natus Medical (NTUS) | United States | $1.031B | 24.02 |
| Accelerate Diagnostics (AXDX) | United States | $0.977B | 0.00 |
| CryoLife (CRY) | United States | $0.974B | 92.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.952B | 29.89 |
| Inogen (INGN) | United States | $0.940B | 23.05 |
| Tactile Systems Technology (TCMD) | United States | $0.924B | 114.19 |
| Luminex (LMNX) | United States | $0.921B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.857B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.852B | 39.38 |
| Quotient (QTNT) | Switzerland | $0.714B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.699B | 22.87 |
| AxoGen (AXGN) | United States | $0.573B | 0.00 |
| Intersect ENT (XENT) | United States | $0.503B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.464B | 0.00 |
| Si-Bone (SIBN) | United States | $0.457B | 0.00 |
| Fluidigm (FLDM) | United States | $0.443B | 0.00 |
| ViewRay (VRAY) | United States | $0.387B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.372B | 14.29 |
| GenMark Diagnostics (GNMK) | United States | $0.369B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.343B | 0.00 |
| Sientra (SIEN) | United States | $0.316B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.312B | 52.75 |
| Accuray (ARAY) | United States | $0.269B | 0.00 |
| IRadimed (IRMD) | United States | $0.239B | 39.62 |
| RTI Surgical (RTIX) | United States | $0.222B | 33.33 |
| SeaSpine Holdings (SPNE) | United States | $0.204B | 0.00 |
| Neuronetics (STIM) | United States | $0.178B | 0.00 |
| Stereotaxis (STXS) | United States | $0.167B | 0.00 |
| ConforMIS (CFMS) | United States | $0.126B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.086B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.069B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.063B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.062B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.052B | 0.00 |
| Vermillion (VRML) | United States | $0.052B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.036B | 0.00 |
| Nuvectra (NVTR) | United States | $0.028B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.027B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.026B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.025B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.025B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.021B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.018B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.016B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Dynatronics (DYNT) | United States | $0.012B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
